The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characteristics and anticancer interventions (ACIs) in African American (AA) and Caucasian (CAU) patients (pts) treated with sipuleucel-T (sip-T): Real-world experience from the PROCEED registry.
 
Andrew J. Armstrong
Honoraria - Dendreon; Sanofi
Consulting or Advisory Role - Bayer; Dendreon; Janssen Biotech; Medivation; Novartis; Sanofi
Speakers' Bureau - Dendreon; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); ImClone Systems (Inst); Janssen Oncology (Inst); KangLaiTe (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture technology (Inst)
Travel, Accommodations, Expenses - Dendreon; Janssen Biotech; Medivation
 
Celestia S. Higano
Employment - Cell Therapeutics (I)
Leadership - Cell Therapeutics (I)
Stock and Other Ownership Interests - Cell Therapeutics (I)
Consulting or Advisory Role - AbbVie; Bayer; BHR Pharma; Dendreon; Ferring; Genentech; Johnson & Johnson; Medivation; Orion; Pfizer; Sanofi
Research Funding - Algeta/Bayer (Inst); Aragon Pharmaceuticals (Inst); AstraZeneca (Inst); Dendreon (Inst); Emergent BioSolutions (Inst); Exelixis (Inst); Genentech (Inst); Medivation (Inst); Millennium (Inst); Oncogenex (Inst); Sanofi (Inst); Teva (Inst)
Travel, Accommodations, Expenses - AbbVie; Amgen; Astellas Pharma; Bayer; Dendreon; Ferring; Genentech; Johnson & Johnson; Medivation; Ockham; Orion; Pfizer; Sanofi; Teva
 
Matthew R. Cooperberg
Honoraria - Takeda
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon; Myriad Pharmaceuticals
Research Funding - GenomeDx; Genomic Health (Inst); Myriad Pharmaceuticals (Inst)
 
Chiledum Ahaghotu
Employment - Steward Healthare System
Leadership - Carney Hospital
Stock and Other Ownership Interests - Cryopartners
 
Ronald F. Tutrone
Stock and Other Ownership Interests - Nymox; Sophiris Bio
Honoraria - Nymox
Consulting or Advisory Role - Medivation/Astellas
Speakers' Bureau - Dendreon; Medivation/Astellas
Research Funding - Advaxis (Inst); American Medical Systems (Inst); Bayer (Inst); Boston Scientific (Inst); Genomic Health (Inst); Janssen Oncology (Inst); MDxHealth (Inst); Medivation/Astellas (Inst); Nymox (Inst); Sophiris Bio (Inst)
 
Laurence H. Belkoff
No Relationships to Disclose
 
Carl A. Olsson
No Relationships to Disclose
 
Sanjay Goel
Research Funding - Dendreon (Inst)
 
Robert Claude Tyler
Employment - Dendreon; Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Nancy N. Chang
Employment - Dendreon
Stock and Other Ownership Interests - Valeant Pharmaceuticals International
 
Jennifer Susan LIll
Employment - Dendreon
Stock and Other Ownership Interests - Bristol-Myers Squibb; Valeant Pharmaceuticals International
 
A. Oliver Sartor
Consulting or Advisory Role - Algeta ASA; Aragon Pharmaceuticals; Astellas Pharma; Bavarian Nordic; Bayer; Bellicum Pharmaceuticals; Biscayne Pharmaceuticals; Johnson & Johnson; Medivation; Oncogenex; Pfizer; Sanofi
Research Funding - Algeta ASA (Inst); Bayer (Inst); Johnson & Johnson (Inst); Progenics (Inst); Sanofi (Inst); Takeda (Inst)